Skip to main content
LONA
NASDAQ Life Sciences

Cash Falls to $32.3M as Q3 Net Loss Widens to $21.2M; ELAINE-3 Enrollment Slips to 4Q 2026

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$3.23
Mkt Cap
$30.432M
52W Low
$2.21
52W High
$14.21
52W Position info
46% above low
Off High info
77% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

LONA sits 46% above its 52-week low of $2.21 on light trading volume (0.3× avg).

Summary

LeonaBio ended September with $32.3M in cash, cash equivalents and investments, down from $88.3M at December 31, 2025, while burning $18.98M in operations during the quarter. R&D spending jumped to $14.6M from $2.8M a year earlier on ELAINE-3 trial costs, pushing the net loss to $21.2M, or $0.89 per share. The company now says it will complete ELAINE-3 enrollment in 4Q 2026, with topline data not expected until 2H 2027 — a long gap for a company this size. That cash balance is thin against the current burn rate, and the prior 10-Q already carried a going concern warning; the 23M Series A warrants that became exercisable in September could bring in up to $146.2M if exercised, which is now the key funding lever. Watch warrant exercise activity and any financing announcement before the cash runs down.

At the time of this announcement, LONA was trading at $3.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.4M. The 52-week trading range was $2.21 to $14.21. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

LONA - Latest Insights

LONA
Nov 16, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.23
Real-time Price: $3.23 info
Change: $0 (0%) info
Market Cap: $30.432M info
LONA
Sep 22, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.05
Real-time Price: $3.23 info
Change: -$2.82 (-47%) info
Market Cap: $30.432M info
LONA
Aug 31, 2026, 4:31 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $7.92
Real-time Price: $3.23 info
Change: -$4.69 (-59%) info
Market Cap: $30.432M info
LONA
Aug 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $3.23 info
Change: -$4.78 (-60%) info
Market Cap: $30.432M info
LONA
Aug 14, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.97
Real-time Price: $3.23 info
Change: -$4.73 (-59%) info
Market Cap: $30.432M info